Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Findling

Showing results (181-190 of 443) with videos related to

Pageof 45
Sort By:
Journal of Child and Adolescent Psychopharmacology|November 30, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive DisorderSarah Atkinson, Shannon Lubaczewski, Sara Ramaker, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 24, 2007
Pharmacotherapy of aggression in a 9-year-old with ADHDRobert L Findling, Jeffrey H Newcorn, Richard P Malone, et al.
The Journal of Clinical Psychiatry|July 12, 2012
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal designMatthew Brams, Richard Weisler, Robert L Findling, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 3, 2014
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of ChildrenAndrea M Yee, Guillermo Perez Algorta, Eric A Youngstrom, et al.
Psychological Assessment|September 28, 2011
Portability of a screener for pediatric bipolar disorder to a diverse settingAndrew J Freeman, Eric A Youngstrom, Thomas W Frazier, et al.
Neuropsychologia|January 17, 2004
Hemodynamic differences in the activation of the prefrontal cortex: attention vs. higher cognitive processingMotomi Toichi, Robert L Findling, Yasutaka Kubota, et al.
CNS Neuroscience & Therapeutics|February 29, 2016
Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized TrialsLinda A Wietecha, David B Clemow, Andrew S Buchanan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 25, 2003
A prospective, open-label trial of olanzapine in adolescents with schizophreniaRobert L Findling, Nora K McNamara, Eric A Youngstrom, et al.
Journal of Child and Adolescent Psychopharmacology|July 19, 2016
Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive DisorderRobert L Findling, James Groark, Karen A Tourian, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Pageof 45

Showing results (181-190 of 443) with videos related to

Sort By:
Pageof 45
Journal of Child and Adolescent Psychopharmacology|November 30, 2017
Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive DisorderSarah Atkinson, Shannon Lubaczewski, Sara Ramaker, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 24, 2007
Pharmacotherapy of aggression in a 9-year-old with ADHDRobert L Findling, Jeffrey H Newcorn, Richard P Malone, et al.
The Journal of Clinical Psychiatry|July 12, 2012
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal designMatthew Brams, Richard Weisler, Robert L Findling, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|June 3, 2014
Unfiltered Administration of the YMRS and CDRS-R in a Clinical Sample of ChildrenAndrea M Yee, Guillermo Perez Algorta, Eric A Youngstrom, et al.
Psychological Assessment|September 28, 2011
Portability of a screener for pediatric bipolar disorder to a diverse settingAndrew J Freeman, Eric A Youngstrom, Thomas W Frazier, et al.
Neuropsychologia|January 17, 2004
Hemodynamic differences in the activation of the prefrontal cortex: attention vs. higher cognitive processingMotomi Toichi, Robert L Findling, Yasutaka Kubota, et al.
CNS Neuroscience & Therapeutics|February 29, 2016
Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized TrialsLinda A Wietecha, David B Clemow, Andrew S Buchanan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 25, 2003
A prospective, open-label trial of olanzapine in adolescents with schizophreniaRobert L Findling, Nora K McNamara, Eric A Youngstrom, et al.
Journal of Child and Adolescent Psychopharmacology|July 19, 2016
Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive DisorderRobert L Findling, James Groark, Karen A Tourian, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Pageof 45